Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$2.81 - $12.91 $1,967 - $9,037
-700 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$3.81 - $9.79 $2,667 - $6,852
700 New
700 $6,000

Others Institutions Holding CELU

About Celularity Inc


  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $442M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Ovata Capital Management LTD Portfolio

Follow Ovata Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ovata Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ovata Capital Management LTD with notifications on news.